TARDBP and Mental deterioration: The development and validation of biomarkers that detect the pathogenic aggregates of TDP-43 and related pathological proteins in vivo are notably expected to further elucidate the pathophysiological mechanisms underlying the basic disorder and the ensuing cognitive decline.